当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析

益丰药房

(603939)

  

流通市值:308.62亿  总市值:308.68亿
流通股本:12.12亿   总股本:12.12亿

益丰药房(603939)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润9.46亿元,每股收益0.73元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1188516.71万元,未分配利润576175.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2631821.64万元,负债1443304.93万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入11,721,819,634.466,009,043,521.2724,062,154,701.7317,218,897,862.76
营业总成本10,538,133,417.855,391,078,498.3621,973,892,618.6515,712,009,022.92
其他经营收益
营业利润1,272,348,418.64650,541,861.922,203,824,345.081,585,544,439.53
利润总额1,263,589,794.94647,828,853.772,182,447,381.721,579,992,160.75
净利润945,793,936.37493,549,281.071,652,782,285.861,198,418,466.02
每股收益
其他综合收益32,352,8259,609,750-69,190,200-89,370,675
综合收益总额978,146,761.37503,159,031.071,583,592,085.861,109,047,791.02
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计14,699,680,085.9515,875,515,074.2715,855,782,213.5114,674,572,132.89
非流动资产:
非流动资产合计11,618,536,351.3811,911,046,281.7912,118,954,736.8412,536,930,162.89
资产总计26,318,216,437.3327,786,561,356.0627,974,736,950.3527,211,502,295.78
流动负债:
流动负债合计10,639,572,046.1612,103,474,750.8212,598,073,700.8112,287,188,811.94
非流动负债:
非流动负债合计3,793,477,289.753,789,883,442.133,983,099,771.614,024,607,391.15
负债合计14,433,049,335.9115,893,358,192.9516,581,173,472.4216,311,796,203.09
所有者权益(或股东权益):
归属于母公司股东权益合计11,153,968,695.5111,185,232,095.2410,725,687,023.4210,253,079,010.09
股东权益合计11,885,167,101.4211,893,203,163.1111,393,563,477.9310,899,706,092.69
负债和股东权益合计26,318,216,437.3327,786,561,356.0627,974,736,950.3527,211,502,295.78
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计13,262,684,876.496,700,021,854.8425,765,047,477.1418,851,751,650.75
经营活动现金流出小计11,693,019,088.35,585,636,163.2621,543,780,392.6115,509,977,272.56
经营活动产生的现金流量净额1,569,665,788.191,114,385,691.584,221,267,084.533,341,774,378.18
投资活动产生的现金流量:
投资活动现金流入小计15,337,215,954.796,051,299,343.6716,105,473,839.6312,419,340,011.15
投资活动现金流出小计15,553,160,522.976,244,952,157.9719,714,322,940.9316,089,737,685.38
投资活动产生的现金流量净额-215,944,568.18-193,652,814.3-3,608,849,101.3-3,670,397,674.23
筹资活动产生的现金流量:
筹资活动现金流入小计1,753,000-1,819,870,756.581,810,363,000
筹资活动现金流出小计1,297,144,025.24440,787,467.612,740,071,008.891,901,026,355.34
筹资活动产生的现金流量净额-1,295,391,025.24-440,787,467.61-920,200,252.31-90,663,355.34
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额58,330,194.77479,945,409.67-307,782,269.08-419,286,651.39
期末现金及现金等价物余额2,219,128,065.292,640,743,280.192,160,797,870.522,049,293,488.22
补充资料:
现金及现金等价物的净增加额58,330,194.77--307,782,269.08-
最新报告期:2025-09-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中银证券刘恩阳1.401.701.902025-09-12
东吴证券苏丰,冉胜男,朱国广1.461.641.842025-09-05
中信建投刘若飞,贺菊颖1.421.631.892025-09-05
招商证券方秋实,梁广楷,许菲菲1.421.641.882025-09-03
信达证券唐爱金,章钟涛1.421.631.882025-09-02
TOP↑